CN1883670A - Liver-benefiting blood circulation-activating eyesight-improving tablet - Google Patents

Liver-benefiting blood circulation-activating eyesight-improving tablet Download PDF

Info

Publication number
CN1883670A
CN1883670A CNA2006100821206A CN200610082120A CN1883670A CN 1883670 A CN1883670 A CN 1883670A CN A2006100821206 A CNA2006100821206 A CN A2006100821206A CN 200610082120 A CN200610082120 A CN 200610082120A CN 1883670 A CN1883670 A CN 1883670A
Authority
CN
China
Prior art keywords
raw materials
fructus
blood circulation
liver
mumiyah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006100821206A
Other languages
Chinese (zh)
Inventor
端智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2006100821206A priority Critical patent/CN1883670A/en
Publication of CN1883670A publication Critical patent/CN1883670A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a tablet for benefiting liver, promoting blood circulation and improving acuity of vision which comprises the raw materials of (by weight ratio) gypsum rubrum 90-130g, iron powder 60-90g, aragonite 60-90g, cane sugar 300-500g, starch 20-55g, magnesium stearate 15-35g, tabasheer, safflower, clove, chebula fruit, belleric terminalia fruit, emblic leafflower fruit, licorice root, multibanded krait, Epuisetum hiemale, caraway seeds, Meconopsis integrifolia, Mumiyah-asil each 20-40g.

Description

Liver-benefiting blood circulation-activating eyesight-improving tablet
One, technical field: the invention belongs to the Tibetan medicine technical field, particularly a kind of tablet that has the liver benefiting, invigorates blood circulation, makes eye bright effect.
Two, technical background:
Existing Tibetan medicine has the liver benefiting, the medicament categories of the effect of invigorating blood circulation, make eye bright is less, a kind of dosage form of the watered pill is only arranged, the deficiency that it exists is that drug effect is undesirable, pill clothes back is slow in the gastrointestinal tract disintegrate, and effective ingredient discharges also slow, and it is slow promptly to be effect property, in addition owing to pharmaceutical factory equipment, workshop hygiene miscarriage, also can cause microbial contamination, it easily goes mouldy, poor stability.
Three, summary of the invention:
The objective of the invention is to develop a kind of tablet of new prescription at the prior art above shortcomings, it has effectively overcome the deficiencies in the prior art, and it has good drug efficacy, and medicine stability is good, do not go mouldy, medicine disintegrate in gastrointestinal tract is fast, is to imitate soon good absorbing, dosage is accurate, production cost is low, has effectively covered the bitterness and the stink of medicine discomfort, many advantages such as easily swallow.
Technical scheme is: this liver-benefiting eye-brightening sheet is to be made by following proportioning raw materials and manufacture method: (one), proportioning raw materials are: calcite 90~130g, Concretio Silicea Bambusae 20~40g, Flos Carthami 20~40g, Flos Caryophylli 20~40g, Fructus Chebulae 20~40g, Fructus Terminaliae Billericae 20~40g, Fructus Phyllanthi 20~40g, Radix Glycyrrhizae 20~40g, Bungarus Parvus 20~40g, Herba Equiseti Hiemalis 20~40g, caraway 20~40g, Herba meconopsis integrifoliae 20~40g, Mumiyah-asil 20~40g, iron powder 60~90g, aragonite 60~90g; Sucrose 300~500g, starch 20~55g, magnesium stearate 15~35g; (2), manufacture method is: earlier above-mentioned raw materials is prepared burden by said ratio, again Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae, Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, 12 kinds of raw materials of Mumiyah-asil are decocted with water 2-3 time, the each decoction 1.5-3.5 hour, collecting decoction, filter and remove residue, filtrate concentrates deicer and makes extractum, calcite, iron powder, aragonite are ground into fine powder, with extractum, sucrose, mix homogeneously is made granule, and dry again back adds starch, the magnesium stearate compression molding gets product.Sucrose, starch, magnesium stearate are the raw material of pharmaceutical purpose, and all the other 15 clock raw materials are medical material clean, sanitary, that can be used as medicine, and wherein iron powder is the powder that can be used as medicine through artificial infusion.
Tablet of the present invention has good drug efficacy, and toxic and side effects is little, and medicine stability is good, does not go mouldy, and medicine disintegrate in gastrointestinal is fast, is to imitate soon, and good absorbing does not have bitterness and abnormal flavour when people take, and easily swallows processing technology science, advantage such as reasonable.When taking 2-3 time on the one, each 2-5 sheet.
Four, the specific embodiment:
Embodiment one: press calcite 90g, seven kinds of medical materials such as Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae are 20g, and five kinds of raw materials such as Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, Mumiyah-asil are 40g, iron powder 90g, aragonite 90g, sucrose 500g, starch 55g, magnesium stearate 35g prepares burden, decoct 2 times during decoction, decocted 3.5 hours collecting decoction at every turn when decocting, filter and remove residue is made tablet by the manufacture method of technical scheme subsequently.
Embodiment two: press calcite 1.3kg, seven kinds of medical materials such as Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae are 0.4kg, and five kinds of raw materials such as Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, Mumiyah-asil are 0.2kg, iron powder 0.6kg, aragonite 0.6kg, sucrose 3.0kg, starch 0.2kg, magnesium stearate 0.15kg prepares burden, decoct 3 times during decoction, decocted collecting decoction at every turn 1.5 hours, filter waste, tablet is made by the manufacture method of technical scheme in the back.

Claims (1)

1. liver-benefiting blood circulation-activating eyesight-improving tablet, it is characterized in that what it was made by following proportioning raw materials and manufacture method: (one), proportioning raw materials are: calcite 90~130g, Concretio Silicea Bambusae 20~40g, Flos Carthami 20~40g, Flos Caryophylli 20~40g, Fructus Chebulae 20~40g, Fructus Terminaliae Billericae 20~40g, Fructus Phyllanthi 20~40g, Radix Glycyrrhizae 20~40g, Bungarus Parvus 20~40g, Herba Equiseti Hiemalis 20~40g, caraway 20~40g, Herba meconopsis integrifoliae 20~40g, Mumiyah-asil 20~40g, iron powder 60~90g, aragonite 60~90g, sucrose 300~500g, starch 20~55g, magnesium stearate 15~35g; (2), manufacture method is: earlier above-mentioned raw materials is prepared burden by said ratio, again Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae, Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, 12 kinds of raw materials of Mumiyah-asil are decocted with water 2~3 times, the each decoction 1.5~3.5 hours, collecting decoction, filter and remove residue, filtrate concentrating dewaters and makes extractum, calcite, iron powder, aragonite are ground into fine powder, make granule with extractum, sucrose mixing, dry again back adds starch, and the magnesium stearate compression molding gets product.
CNA2006100821206A 2006-05-27 2006-05-27 Liver-benefiting blood circulation-activating eyesight-improving tablet Pending CN1883670A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006100821206A CN1883670A (en) 2006-05-27 2006-05-27 Liver-benefiting blood circulation-activating eyesight-improving tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2006100821206A CN1883670A (en) 2006-05-27 2006-05-27 Liver-benefiting blood circulation-activating eyesight-improving tablet

Publications (1)

Publication Number Publication Date
CN1883670A true CN1883670A (en) 2006-12-27

Family

ID=37582054

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100821206A Pending CN1883670A (en) 2006-05-27 2006-05-27 Liver-benefiting blood circulation-activating eyesight-improving tablet

Country Status (1)

Country Link
CN (1) CN1883670A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966328A (en) * 2019-04-29 2019-07-05 白吉日木吐 Ellagic acid and the extracting method of chebulinic acid and combinations thereof in a kind of myrobalan

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966328A (en) * 2019-04-29 2019-07-05 白吉日木吐 Ellagic acid and the extracting method of chebulinic acid and combinations thereof in a kind of myrobalan

Similar Documents

Publication Publication Date Title
CN1840128A (en) Medicine for treating cardiovascular disease
CN101297889B (en) Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof
CN107801999A (en) A kind of folium cortex eucommiae buccal tablet with vasorelaxation action
CN1170549C (en) Process for preparing 'Qianjin' capsule to treat genopathy
CN101507697B (en) Purple beautyberry mouth wash
CN1158087C (en) Process for preparing 'Qianjin' capsule to treat ganopathy
CN103800795A (en) Traditional Chinese medicine for treating gastric ulcer
CN109528868A (en) A kind of Chinese medicine composition treats aphthae in preparation, the application in the drug of carbuncle swells furunculosis
CN101966261A (en) Medicament for treating high blood pressure and preparation method thereof
CN1883670A (en) Liver-benefiting blood circulation-activating eyesight-improving tablet
CN110870567B (en) Edible granules for relieving gout and preparation method thereof
CN1883671A (en) Liver-benefiting blood circulation-activating eyesight-improving granule
CN1203887C (en) Traditional Chinese medicine for treating arthralgia and preparation process thereof
CN1517115A (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN102526462B (en) Traditional Chinese medicine composition for treating tinnitus
CN1240655A (en) Face-nursing stigma croci tea and its making method
CN107308254A (en) Eight positives and preparation method thereof
CN103070337A (en) Defaecation-promoting health-care food and preparation method thereof
CN101919983A (en) Chinese materia medica preparation for treating gastritis chronic cholecystitis
CN101357221A (en) Traditional Chinese medicine preparation for treating female coldness
CN100353987C (en) Chinese medicinal preparation for treating acne
CN1813924A (en) Eight-ingredient amur barberry bark capsule
CN103933267A (en) Traditional Chinese medicinal composition for treating toothache and preparation method thereof
CN1292763C (en) Chinese traditional medicine buccal tablets for preventing and treating caries and its preparation
CN1084198C (en) Psoriasis treating Chinese medicine bolus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication